Infectious diseases caused by antimicrobial-resistant pathogens are estimated to surpass cancer as the second largest cause of death by 2050. Every year, antimicrobial resistance leads to 33 000 deaths in the EU and €1.5 billion losses in productivity and healthcare measures. Yet, no new classes of antimicrobials have been discovered in the past 30 years. Present uncertainties, such as the looming economic recession and the acceleration of climate change, are additional elements that put further pressure on an already fragile public health ecosystem.

Building on the existing body of evidence regarding the multidimensional determinants and socioeconomic impacts of antimicrobial resistance, the STOA workshop will focus on the exploration of solutions to tackle this growing public health crisis, from research innovations in monitoring, therapeutics and vaccines, to a discussion of new inputs for policymaking. A series of experts from different academic fields across Europe will discuss possible ways forward. The STOA workshop will contribute to the Parliamentary discussion on the upcoming revision of the EU general pharmaceuticals legislation.

10:00-10:05 Welcome and introductory remarks

· Lina GÁLVEZ MUÑOZ, MEP and STOA Panel member

10:05 - 10:50 Research & innovation

· Frank AARESTRUP, Professor of Microbiology, Technical University of Denmark

· Francesco IMPERI, Professor of Microbiology, University Roma Tre, Italy

· Pedro MADUREIRA, Co-founder and CSO, Immunethep, Portugal

10:50 - 11:35 Policy strategies

· Malin GRAPE, Ambassador on AMR, Ministry of Health and Social Affairs, Sweden

· Ellen 'T HOEN, Director, Medicines Law and Policy, Netherlands

· Clare CHANDLER, Professor, London School of Hygiene & Tropical Medicine, UK

11.35 - 11.55 Q&A session

11:55 - 12:00 Closing remarks

· Lina GÁLVEZ MUÑOZ, MEP and STOA Panel member

The event will be held in English with interpretation into French, Italian and Spanish.